EUVIMEDEUVIMED entdecken
Crossref

Engineered Biomimetic Nanovesicles Derived From Bone Marrow Stromal Cells With Innate Homing Capability for Targeted Delivery

Wenjuan Ma, Yuting Yang, Binbin Yang, Bicai Tang, Long Bai, Yao He, Yong Li, Yunfeng Lin iD

Advanced Materials · 2025-11 · 37 (45)

DOI: 10.1002/adma.202505714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 29.08.2025. Verfasst von Wenjuan Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, C…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Biomimetic Materials, Drug Delivery Systems, Drug Carriers. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Youth Science and Technology Innovation Team, Research and Develop Program West China Hospital of Stomatology Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precise delivery of pharmaceuticals administered to bone marrow for various bone diseases is challenging, given the bone marrow‐blood barrier (MBB). Bone marrow stromal cells (BMSCs) derived from bone marrow can naturally infiltrate the MBB and home to bone tissue. Here, biomimetic nanovesicles (namely mNVs) engineered with the extracted cell membrane from BMSCs are reported for homing delivery of different core nanomedicines to bone marrow. The cargo‐loaded mNVs exhibited excellent bone targeting in crossing natural barriers is demonstrated to augment drug concentrations in bone marrow, and the bio‐function of mNVs is verified in typical models of chronic metabolic bone disease and metastatic carcinoma. In the induced osteoporosis model, engineered mNVs deliver the nanocore of teriparatide‐loaded poly(lactic‐co‐glycolic acid), forming a sustained‐release system of teriparatide, which can significantly slow bone loss, maintain bone mass, and alleviate osteoporosis indicators. In osseous and systematic metastatic breast carcinoma models, the mNVs are employed to deliver DNA tetrahedron embedded doxorubicin and efficiently inhibit tumor progression and osteolytic lesions. This work suggests that high‐efficiency bone marrow delivery of medications can be camouflaged by the cell membrane derived from BMSCs, initiating a new platform for bone targeting drug delivery for developing more effective therapeutics for bone diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsBiomimetic MaterialsDrug Delivery SystemsDrug CarriersAnimalsDoxorubicinMiceHumansPolylactic Acid-Polyglycolic Acid CopolymerFemaleOsteoporosisCell Line, Tumor

Stichwörter der Autor:innen

biomimetic nanovesiclebone marrow stromal cellscell membrane coatingmetastatic breast cancerosteoporosisteriparatidetetrahedral framework nucleic acid

Substanzen

DoxorubicinPolylactic Acid-Polyglycolic Acid CopolymerDrug Carriers

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, P.R. China.
  • Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, P.R. China.
  • Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu, Sichuan, 610041, P.R. China.
  • National Engineering Research Center for Biomaterials, Sichuan University, No. 29, Wangjiang Road, Chengdu, Sichuan, 610064, P.R. China.
  • Department of The Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, P.R. China.
  • Department of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, P.R. China.

ORCID-Profile: Yunfeng Lin

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Youth Science and Technology Innovation Team
  • Research and Develop Program West China Hospital of Stomatology Sichuan University
  • Health Commission of Sichuan Province Medical Science and Technology Program, the Postdoctoral Fellowship Program of CPSF
  • Sichuan Province Innovative Talent Funding Project for Postdoctoral Fellows
  • Sichuan Science and Technology Program

Zitieren

APA

Ma, W., Yang, Y., Yang, B., Tang, B., Bai, L., He, Y., Li, Y., & Lin, Y. (2025). Engineered Biomimetic Nanovesicles Derived From Bone Marrow Stromal Cells With Innate Homing Capability for Targeted Delivery. Advanced Materials, 37(45). https://doi.org/10.1002/adma.202505714

Vancouver

Ma W, Yang Y, Yang B, Tang B, Bai L, He Y, et al. Engineered Biomimetic Nanovesicles Derived From Bone Marrow Stromal Cells With Innate Homing Capability for Targeted Delivery. Advanced Materials. 2025;37(45). doi:10.1002/adma.202505714

BibTeX
@article{Ma2025,
  author = {Ma, Wenjuan and Yang, Yuting and Yang, Binbin and Tang, Bicai and Bai, Long and He, Yao and Li, Yong and Lin, Yunfeng},
  title = {Engineered Biomimetic Nanovesicles Derived From Bone Marrow Stromal Cells With Innate Homing Capability for Targeted Delivery},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {45},
  doi = {10.1002/adma.202505714}
}
Kostenlos starten →